<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 343 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page342.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=343">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 343 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 343</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=343"><img src="../thumb/343.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>306 / 2020-04                                                       Endocrine System - 19.6.5 / 19.7
   Contraindications: Pregn.& lactat., hormone depend.tumours,   logic.prob.such as weakn. &/or paraesthes.of low.limbs.or worsen.  Contra-indications: Pregn., breast feed., evid.of active tumour,
   known/past/suspect.breast Ca., known/suspect.oestrog.-de-  of urin.sympts., loc.inj.site reacts., hot flush., sweat., insomn., syn-  intracran.les.must be inact.& anti-tumour ther.complete bef.com-
   pend.malign.tumours, vag.bleed.of unknown aetiol., untreat.  cope, rigors, weakn., lethargy, urin. freq., noctur., GI disturbs., decr.  menc.ther., childr. with clos.epiphyses for growth promot.indicat.,
   endometr. hyperplas., CV/cerebrovasc.disords./hist.thereof,   RBC count/ haematocrit. & Hb, weight gain, trem., backache, joint   m-cresol hypersens.
   prev.idiopath./curr.ven.thromboembol., known thrombophilic   pain, musc.atrophy, limb pain, smell & taste disturb., depress., ver-  Side-effects: Loc.skin react., allerg.reacts., hyperlipidaem., hae-
   disords., any hist.of thromboembol. dis.(eg.angina/MI/stroke/  tigo, testic.soren./-atrophy, impot., decr. libido, gynaecomast., breast   matur., hypocalcaem., albuminur., ac. leukaem.but no certain assoc.
   TIA), sev.liv.dis., porphyr.. heredit.galact.intol./Lapp lact.defic.or   soren/ tendern., erect.dysfunct., penile disords., reduc. penis size,   found, benign intracran.hypertens.report.
   gluc.-galact.malabsorpt.     prurit., alopec., clammin., night sweats, incr.sweat., hypertens./hy-  Special precautions: Monit.pan hypopituitarism pts.caref., ren.
   Side effects: Low. abdom.pain, abnorm.hair growth, acne, vag.dis-  potens., decr.bone densit.  funct.to be bel.50% of norm.bef. instit.ther.in chron.ren.insuffic., est.
   charge/mycos./haemorrh., endometr.wall thicken., post menopaus.  Special precautions: Worsen.of sympts.& onset of new S&S   conserv.ren. insuffic.treatm.& maint.dur.treatm., discont.aft. ren.
   haemorrh., breast tender./discomf., fung.infect., nipple pain, genit.  eg.tempor.incr.in bone pain/ neuropathy /haematur./bladd.outlet   transpl., verify HGH defic., do not shake to mix., safety of admin.for
                                                          st
   prurit./discharg., pelv.pain, cervic.dysplas., vulvovaginit,. weight   obstruct./ ureter. obstruct.& spin.cord compress.report.dur.1  wks.   long.than 12 mnths.not est., confirm diagn.bef. treatm.starts., ad-
   incr., abnorm.cervic.smear, amnes., dizzin., rash, prurit., seborrh.  of treatm.theref.caref.monit.reqd.in pts.with metastat. vertebr.les.  just insul. dos.in diabet., pts.with growth hormone defic. second. to
   dermatos., headache, migr., vis.disturbs., GI upset, depress., oed.,   and/or urin.tract.obstruct.  intracran.les. must be exam.freq.for progress. or recurr.of underly.
   arthralg., myalg., liv.funct.param.changes.  FERTOMID, Cipla Medpro  dis., investigat. poss. papilloed.in case of sev./ recurr. headache/
   Special precautions: Not for contracept.use, avoid use until12   Clomiphene citrate.  vis. probl. & N/V, limp.in childr.to excl. slipp.hip epiphys., resist.
   mnths.aft.last menstr.bleed, discont.if signs of thrombo-embol.pro-  Indications: Anovulat.infertil.where hypothalm.-hypophyseal-ovar.  to therapeut.eff., hypothyroid., hypoglycaem.(init./aft.cessat.), hy-
   cess.occur./ abnorm.liv.funct.tests/appear.of cholestat.jaund., inves-  syst.are funct.& endogen. oestrog.are adeq.  perglycaem. dur. ther.
   tig.vag.bleed.commenc.aft.3 mnth.treatm./ recurr./ of long durat., in-  (S4) TABS. 31/18.8/0625.  See also MDR page 617.
   duc.withdr.bleed.with a progestagen when chang.ther., teratogen.  840270-003: 50 mg, 10, R125,12  GONAL-F, (Biopharma Div) Merck [P/S] &
   in experim. anim.therfore do not admin to premenopaus. women.,   Dosage: 1st course 1 tab dly x5 days. If ovulat. has not occur.give   Follitropin alfa.
   period.examin.for endometr. hyperplas.& poss.virilisat., eval.benef.   2nd course of 2 tabs dly x5 days. 3 courses is consid.adeq.trial. Re-  Indications: Multip.follicle developm.in assist. reproduct.technolog.
   vs risk, monit.pts.where leiomyoma/ thromboembol. dis.hist or risk   eval. diagnos. if ovulat.menses has not occur. Ovulat. usual. occurs   (S4) INJ, 33/21.10/0521, A39/21.10/0631, 0632, 0633
   pres./oestrog. depend. tumour risk fact./hypertens./liv.disords./ diab.   betw.days 6-12 aft.a course. Correctly timed coitus is imp. Once ovu-  896613-006: 75 IU, 1 vial + solv., R294,29
   mellit.with or without vasc.involvem./ cholelithias. /migraine or sev.  lat.est.to maint. reg. cycl.ovulat.each course to be start on/ about   707508-001: 300 IU/0,5 ml pen, R1 198,61
   headache/SLE/ endometr.hyperplas./epilep./asthma or otoscleros   the 5th cycle day. Long-term treatm.beyond total of 6 cycles (incl. 3   707509-001: 450 IU/0,75 ml pen, R1 797,90
   are pres.or have occur.prev., discont.if jaund./ deteriorat. liv.funct./  ovulat.cycles) not recomm.  707510-001: 900 IU/1,5 ml pen, R3 595,82
   signific.BP incr. or new onset of migraine type headache, incr.endo-  Contraindications: Pregn., pituit.fail., liv.dis., ment.depress., en-  Dosage: Admin.SC inj.accord.to manufact.lit.
   metrial/ breast & ovar.Ca diagnos.risk, VTE risk, consid. prophylact.   dometr.Ca., abnorm.uter.bleed., ovar. cysts, act.thrombophlebit.,   Admin.150-225 IU dly.start.on days 2-3 of cycle, cont. treatm.until.
   VTE meas.post-op, benef.-risk with concom. anticoag.ther., incr.is-  safety in lactat. not est.  adeq.follicul.developm.achiev. adjust.dos.accord.to respons.usual.
   chaem.stroke risk, dement.over 65 yrs.  Side effects: Ovar.enlargem., cyst format., vasomot. flush., ab-  not high.than 450 IU dly. Gen adeq.follucul.developm.achiev.by 10   th
   Drug interactions: Potent.theoretic.interacts: enzyme-induc.com-  dom./pelv.discomf., N&V, CNS eff., breast tendern., abn.uterine   day within range of 5 -20 days. To induc.fin. follicul.maturat.admin.
   pds.may enhanc.metabol.thus decr.therapeut.eff., eff.of anticoags.  bleed., weight gain, incr.urin.flow, trans.vis.disturbs., skin reacts.,   sngl.inj.of 10 000 IU of hCG 24-48 hrs.aft.last inj.
   poss.enhanc. since bld.fibrinolyt.activ.poss.incr.  revers.alopec., hydatidiform mole format., syncope, CVA, centr.  When down regulat.with GnRH is used init. treatm. 2 wks.aft.start
                                thrombos., psychot.reacts.    of agon.treatm.at 150-225 IU x1st 7 days then adjust according to
                                Special precautions: Monit.bas.body temp.to determ. ovulat.& if   ovar. respons. contin. with both until adeq.follic. developm. achiev.
   19.7   Tropic hormones       it is biphas.& not follow.by menses pregn./ovar.cyst poss., polycyst.  Contraindications: Uncontr.thyroid./adren. dysfunct., prim.ovar.
                                                              fail., ovar.enlargem./ cyst not due to polycyst.ovar.dis., gynaecolog.
                                ovar., poss. multiple pregn., discont.in case of vis. disturbs., & do
   FERTAB (MDR Listing)         ophthalm.examinat., pt.to report abdom./ pelv.pain.  bleed.of unknown origin., ovar./uter./breast Ca, hypothalam. /pituit.
   GENOTROPIN (MDR Listing)     FOSTIMON, Delfran [P/S]       tumours, sex.organ malformat/ uter. fibroid tumours imcompat.with
   GONAL-f (MDR Listing)        Urofollitropin (FSH)          pregn., pregn. & lactat.
                                                              Side effects: Loc.reacts.at inj.site, ovar.cyst, headache, GI disturbs.,
   GONAPEPTYL (MDR Listing)     Indications: Ovulat.induct.in anovulat.women esp. where LH is rais.
   LEUPROLIDE HEXAL (MDR Listing)  (S4) INJ, 42/21.10/0184; 42/34/0185  ovar.hyperstimulat.syndr., ser. thromboembol.complic., ectop.pregn.,
                                                              syst. allerg.reacts.
   LUVERIS (MDR Listing)        714309-001: 75 IU, 1 vial + solv., R262,19  Special precautions: Only for use by exper. physic., monit.ovar.
   MENOPUR (MDR Listing)        714309-002: 75 IU, 10 vials + solv., R2 621,87  respons.with ultrasound & ser. oestrad.lev., fertil.eval.of both partn.
   OVITRELLE (MDR Listing)      Dosage: Admin.by slow IM inj.accord.to manufact.lit. Only for use   bef.start. treatm., ovar.hyperstimulat.syndr.risk, withhold hCG admin.
   PERGOVERIS (MDR Listing)     by exper. physic. Indiv.dos.accord.to ovar.respons.  if ovar.hyperstimulat. develops & avoid sex. intercourse x4 days,
   CLOMID, Adcock Ingram Ltd    Admin.dly. Begin within 1st 7 days of menstrual cycle in menstruat.  multip.pregn.risk., high. incid. of miscarriage/abort.report., benign
   Clomiphene citrate.          pts. Common regimen: 75-150 IU/ day, incr.if necess.by 37,5 IU (up to   & malign. ovar.& other reproduct.system.neoplasms report., slight.
                                75 IU) with interv.of 7-14 days, until adeq.but not excess. respons.
   Indications: Anovulat.infertil..                           high.preval.of congenit.malformat. thought to be due to differ.in
   (S4) TABS. H1745             achiev. Maint.dly.dos.until pre-ovulat. condit. reach., usually 7-14   parent.characterist. e.g matern.age, incr.risk of thrombo-embol.
   714771-007: 50 mg, 5, R111,36  days. Discont.admin.& induc.ovulat.with hCG admin. Decr.dly.dos.  events. if risk fact.preval.
                                if number of respond.follicles too high or oestrad. lev.incr.too rap-
   Dosage: 1st course 50 mg dly x5 days beg.on day 5 of cycle /or   Drug interactions: Concom.use with other ovulat. stimul.agents
   any day if pt.had no rec.uter.bleed.. If ovulat. has not occur.give 2nd   idly. Multiple pre-ovulat.follicles exceed.14 mm carry multiple ges-  poss.potent.ovar.respons., poss. dos. incr.to elicit adeq.response
                                tat.risk & hCG should be withheld and pregn.avoid. Recommence
   course of 100 mg dly.as sngl.dos. x5 days.  next treatm.cycle at a low.dos. If respons.inadeq. aft.4 wks.of treatm   with concom. gonadotroph releas.horm.
   3 courses is consid.adeq.trial. Re-eval.diagnos.if ovulat.menses has   abandon.cycle and recommence at high.init.dos. Once ideal respons.   See also MDR page 500.
   not occur. Ovulat.usual.occurs betw. days 6-12 aft.a course. Correctly   obt.admin.sngl.inj.of 5 000 IU hCG 24-48 hrs.aft. last Fostimon inj.   HUMATROPE, Eli Lilly
   timed coitus is imp. Once ovulat.est.to maint.reg. cycl. ovulat. each   Coitus recomm.the day of hCG inj.& follow.day.  Somatropin (rDNA origin).
   course to be start on/about the 5th cycle day. Long-term treatm.be-  Contraindications: Pregn.& lactat., clomifene citrate, ovar.en-  Indications: Paed.pts: In childr.who have growth fail.due to decr./
   yond total of 6 cycles (incl. 3 ovulat.cycles) not recomm.  largem./cyst not due to polycyst. ovar.syndr., gynaecolog.bleed.of   fail.secret.of norm. endogen. growth hormone which has been veri-
   Contraindications: Pregn., liv.dis., liv.dysfunct. hist., pituit.fail.,   unknown origin., ovar./uter./breast Ca, hypothalam./pituit.gland   fied by thorough pituit.funct. investigat. bef. admin., short stature
   endometr.Ca., ovar.cysts other than polycystic ovary, undiagn.ab-  tumours, where effect.respons.cannot be achiev. eg. prim.ovar.fail./  in Turner’s syndr., growth retardat.in prepubert.childr.with chron.ren.
   norm. uter.bleed.            sex.organ malformat/uter. fibroid tumours imcompat.with pregn.  insuffic., idiopath. short stature where attainm.of adult height within
   Side effects: Vasomot.flush., abdom./pelv. discomf. /pain, ovar.  Side effects: Hyperthyroid., mood swings, headache, lethargy,   norm.range unlikely the epiphyses have not clos.& diagnost.evaluat.
   enlargem., cyst format., vis. disturbs., exagger.variat.in ovar.size   dizzin., dyspn., epistax., GI disturbs., erythema, prurit., cystit., ovar.   has excl.other causes/should be treat.by other means.
   with rare massive ovar.enlargem.& lutein cyst.rupt., N&V, CNS   hyperstimulat. syndr., breast hypertrophy, breast pain, hot flush,   Adults: replacem.of endogen.growth hormone with growth hormone
   effs., mastalg., menorrhag., intermenstr. spott., weight gain, skin   pain, fatig., loc.reacts.at inj.site, arter.thromboembol., prolong.  defic.syndr.who meet both the follow.criteria:
   reacts., incr.urin.freq., mod. revers.alopec., hydatidiform mole for-  bleed.time, ectop. pregn.  1.   Adult onset: When the syndr.either alone/ with multiple hor-
   mat., liv.funct.abnormalit., syncop./faint., CVA, cerebr. thrombos.,   Special precautions: Assess.couple’s infert.as appropr & eval.  mone defic.is as a result of pituit./hypothalam.dis./surg./ra-
   speech disturbs.             putat.C/I’s for pregn., eval.for hypothyroid./adrenocortic.defic./hy-  diat. Ther / trauma or childhood onset when adult pts. were
   Warnings and special precautions: Prolong. treatm.not   perprolactinaem./ pituit.or hypothalamic tumours, multip.pregn. risk.,   growth hormone defic.in childhood and have growth hormone
   recomm., monit.bas.body temp.to determ. ovulat.& if biphas.& not   monit.ovar.respons., ultrasound assessm.& ser.oestrad.lev.when init.  defic. syndr.confirm.as adult.
   follow.by menses excl. pregn., poss.multiple pregn., discont.in case   treatm.& at reg.interv., ovar.hyperstimulat.syndr.risk, withhold hCG   2.   Biochem. diagn.of growth hormone defic. syndr.by means of
   of vis. disturbs., & do ophthalm.examinat., caref. select.of pts., init.  admin. if ovar.hyperstimulat.develops & avoid pregn., high. incid.of   negat.response to std. growth hormone stimulat.test.
   evaluat.to excl.liv.dis./pituit.or ovar.fail.& endometr.neoplasms, pt.to   miscarriage report., confirm intra-uter. pregn.to excl.ectop.pregn.,   (S5) POWD.FOR INJ, 32/21.10/0673, 33/21.10/0310
   report abdom./ pelv.pain/weigh gain/discomf./distens.  benign & malign. ovar. & other reproduct.system.neoplasms report.,   860557-006: 6 mg (18 IU), 1 cartr./pre-fill.syr., R1 415,59
   ELIGARD, Key Oncologics [P/S]  slight.high.preval.of congenit.malformat., incr.risk of thrombo-embol.  866660-003: 12 mg (36 IU), 1 cartr./pre-fill.syr., R2 675,49
                                                              Dosage: See product lit.for reconstitut. Indiv. Admin. SC. Cartridges
   Leuprolide.                  events. if risk fact.preval., transmiss. of infect.agents cannot be to-  design.for use with HumatroPen only.
   Indications: Palliative treatm.of advanc.prostat. Ca.  tally excl. as prepar.from human urine.  Paed.growth horm.defic: Recomm.wkly.dos: 0,18 mg/kg
                                Drug interactions: Concom.clomifene citr.may enhance.follic.respons.
   (S4) INJ.SUSP, A39/26/648, 649, 651                        (0,54 I.U./kg)bm div.into equal dos. given on 3 alt.days.or 6 x/wk.
   716857-001: 7,5 mg, 1xsngl.use pack with Atrigel Del.Syst., R1 670,13  GENOTROPIN, Pfizer &  Adult growth horm.defic: Init.recomm.dos: Not more than 0,006
   716858-001: 22,5 mg, 1xsngl.use pack with Atrigel Del.Syst., R4 178,28  Somatropin.  mg/kg (0,018 I.U./kg) bm/day. Incr.grad.accord.to indiv.requirem.to
   716859-001: 45 mg, 1xsngl.use pack with Atrigel Del.Syst., R6 744,62  Indications: Short stature due to dec./fail. secret.of pituit.growth   max.of 0,0125 mg/kg (0,0375 I.U./kg)/day aft.min.of one month. Ti-
   Dosage: Admin.SC. Continous release of leuprolide over 1-, 3-, or 6   hormone, Turner’s syndr., growth disturbs.in prepubert.childr.with   trat. accord.to S/E & serum insul.-like fact.(IGF-1)to low. effect.dos.
   mnth treatm.period. The inj.del.the dos.of leuprolide incorpor.in poly-  chron. ren.insuff.  Turners syndr: Recomm.dos: 0,17 mg/kg-0,375 mg/kg (0,5 IU-
   mer formulat. Prod.to reach room temp.bef. mix and to be admin.  (S5) INJ. X/21.10/214. 16 IU (5,3 mg)  1,125 IU/kg)/wk. Div.wkly.dos. into 6-7 SC inj.admin.pref.in even.
   within 30 mins.thereof. Rotate inj.site. See lit.for preparat.instruct.  793337-011: 5x1 ml cartridges, R7 071,91  Prepubertal paed.pts.with chron.ren.insuffic: Recomm.dos:
   For dos of 7,5 mg: 1 inj.every mnth. For dos of 22,5 mg: 1 inj.every   Dosage: Short Stature: Indiv. Gen: 0,5-0,7 IU/kg bm/wk or approx.   0,045 mg/kg-0,050 mg/kg/day SC.
   3 mnths. For dos of 45 mg: 1 inj.every 6 mnths.   14-20 IU/m /wk. Div.dose into 6-7 SC inj.  Idiopath.short stature: Recomm.dos: up to 0,37 mg/kg/wk SC div.
                                     2
   Contraindications: GnRH/GnRH agon.analog. hypersens., wom-  Tumer’s syndr: 1,0 IU/kg bm/wk.or 28 IU/m  body surf.area/wk.  into equal dos.admin.6-7x/wk.
                                                   2
   en, paed.pts., pregn.        Chron.ren.insuffic: 30 IU/m  body surf./wk. (approx. 1 IU/kg   Contra-indications: Clos.epiphys., act.tumour, ac. crit.illn.due to
                                              2
   Side effects: Potent.exacerbat.of signs & sympts. of dis.in pts.  bm/wk). High.dos.poss.if growth velocity too low. Poss.dos.cor-  complicat.follow.open heart/ abd./ surg., multip.trauma or ac.resp.
   with vertebr.metastas.&/or urin. obstruct./ haematur.led.to neuro-  rect.aft.6 mnths.  fail., safety in pregn.& lactat.not est.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page342.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page338.html">338</a>&nbsp;&nbsp;&nbsp;<a href="page339.html">339</a>&nbsp;&nbsp;&nbsp;<a href="page340.html">340</a>&nbsp;&nbsp;&nbsp;<a href="page341.html">341</a>&nbsp;&nbsp;&nbsp;<a href="page342.html">342</a>&nbsp;&nbsp;&nbsp;<a href="page343.html">343</a>&nbsp;&nbsp;&nbsp;<a href="page344.html">344</a>&nbsp;&nbsp;&nbsp;<a href="page345.html">345</a>&nbsp;&nbsp;&nbsp;<a href="page346.html">346</a>&nbsp;&nbsp;&nbsp;<a href="page347.html">347</a>&nbsp;&nbsp;&nbsp;<a href="page348.html">348</a>
             </td>
             <td width="35%"><a href="page344.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page344.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
